Johnson & Johnson
Logotype for Johnson & Johnson

Johnson & Johnson (JNJ) investor relations material

Johnson & Johnson Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Johnson & Johnson
Q4 2025 earnings summary21 Jan, 2026

Executive summary

  • Achieved full-year 2025 sales of $94.2B, up 6.0% year-over-year, with operational growth of 5.3% and strong performance across six key business areas.

  • Diluted EPS reached $11.03, up 90.6% year-over-year, including reversal of special charges; adjusted EPS was $10.79, up 8.1%.

  • Both Innovative Medicine and MedTech segments delivered strong operational growth, driven by new product launches, commercial execution, and major acquisitions.

  • 28 platforms/products now generate at least $1B in annual revenue, supporting sustainable growth.

  • 2025 marked by significant R&D and M&A investment ($32B+), major acquisitions (Intra-Cellular Therapies, Halda Therapeutics), and new manufacturing facilities.

Financial highlights

  • Q4 2025 worldwide sales: $24.6B, up 9.1% year-over-year; U.S. sales up 7.5%, international up 11.3%.

  • Q4 net earnings: $5.1B; diluted EPS: $2.10, up 48.9% year-over-year; adjusted net earnings: $6B; adjusted EPS: $2.46, up 20.6%.

  • Full-year 2025 sales: $94.2B, up 6.0%; U.S. up 6.9%, international up 3.4%.

  • Full-year net earnings: $26.8B, up 90.6%; adjusted net earnings: $26.2B, up 8.1%.

  • Free cash flow: $19.7B, with $20B in cash/marketable securities and $48B in debt at year-end.

Outlook and guidance

  • 2026 operational sales growth expected at 5.7%-6.7% (midpoint $100B); reported sales growth 6.2%-7.2%.

  • Adjusted operational EPS guidance: $11.28-$11.48 (midpoint 5.5% growth); reported adjusted EPS: $11.53.

  • Free cash flow expected to rise to ~$21B in 2026.

  • 2026 adjusted pre-tax operating margin to improve by at least 50 bps.

  • Guidance incorporates 53rd week, MedTech tariffs, U.S. government agreement, and higher share count.

Which products offset STELARA's impact in 2025?
What is the status of Orthopaedics separation?
What are the ongoing restructuring programs?
Bridge to double-digit growth by decade end
OTTAVA's unique market position and impact
INLEXZO's market expansion and J-code impact?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Johnson & Johnson earnings date

Logotype for Johnson & Johnson
Q1 202614 Apr, 2026
Johnson & Johnson
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Johnson & Johnson earnings date

Logotype for Johnson & Johnson
Q1 202614 Apr, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Johnson & Johnson, a healthcare conglomerate and manufacturer of consumer products was founded in 1886 by brothers Robert Wood and Johnson Johnson. Today, the company operates in three segments – Consumer Health, Pharmaceutical and Medical Devices. The company sells its products to general public and retail outlets as well as distribute directly to wholesalers, hospitals, healthcare professionals for prescription use.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage